Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) 2025 Q2
Dallas, Texas--(Newsfile Corp. - August 4, 2025) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). In 2Q25, NCSM reported total revenues of $36.5M, a 22.8% year-over-year increase, outperforming broader industry activity levels. Growth was primarily driven by increased fracturing systems activity and frac plug sales in both Canada and the U.S., despite a 52% sequential revenue decline in Canada...
2025-08-04 4:34 PM EDT
Alberta Distillers Limited(R) Elevates Canadian Whisky with New Alberta Premium Golden Rye 9 Year Old
Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - From the foothills of the Canadian Rockies, Alberta Distillers Ltd. introduces Alberta Premium Golden Rye 9 Year Old, a new whisky expression that captures the essence of golden hour in every sip. Crafted with 100 per cent Canadian rye grain and aged for nine years, this release continues the brand's tradition of excellence, while showcasing the full character and complexity of a matured rye. Made using local Canadian ingredients combined...
2025-07-30 8:12 AM EDT
Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) 2025 Q2
Dallas, Texas--(Newsfile Corp. - July 29, 2025) - Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners updates their coverage on Civeo Corporation. CVEO reported 2Q25 revenue, Adj. EBITDA, and Adj. EPS of $162.7M, $25.0M, and ($0.25), respectively. This compares to our/consensus estimates of $167.5M/$163.0M, $25.6M/$22.6M, and $0.03/$0.18, respectively. Revenue was slightly below expectations, with upside driven by the Australian segment and offset by continued macro-driven headwinds in...
2025-07-29 4:31 PM EDT
Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (ARLP) 2025 Q2
Dallas, Texas--(Newsfile Corp. - July 29, 2025) - Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P. ARLP reported a resilient 2Q25, with higher coal sales volumes offset by lower coal pricing and a stable contribution from oil & gas royalty revenues. Total revenues for the quarter decreased by 7.7% year-over-year to $547.5M, primarily due to an 11.3% decline in average coal sales prices and lower transportation...
2025-07-29 8:37 AM EDT
Stonegate Updates Coverage on Third Coast Bancshares, Inc. (TCBX) Q2 2025
Dallas, Texas--(Newsfile Corp. - July 25, 2025) - Third Coast Bancshares, Inc. (Nasdaq: TCBX): Stonegate Capital Partners updates their coverage on Third Coast Bancshares, Inc. For 2Q25, Third Coast reported net income of $16.8M, which is up from $13.6M in 1Q25. This was equal to a basic and diluted EPS of $1.12 and $0.96, respectively. The Q/Q increase was primarily attributed to higher net interest income, driven by opportunistic securitization of the portfolio and stability in expenses...
2025-07-25 9:36 AM EDT
Q.ANT Raises 62 Million to Transform the Future of Computing with Photonic Processing
Stuttgart, Germany--(Newsfile Corp. - July 17, 2025) - Q.ANT, a pioneer in photonic processing, today announced a 62 million Series A financing round to accelerate the commercialization of its energy-efficient photonic processors for artificial intelligence (AI) and high-performance computing (HPC). The round is co-led by Cherry Ventures, UVC Partners and imec.xpand with participation from additional deep tech investors, including L-Bank, Verve Ventures, Grazia Equity, EXF Alpha of Venionaire...
2025-07-17 5:35 AM EDT
InFlectis BioScience Announces Publication of Groundbreaking Study on IFB-088's Therapeutic Potential in ALS in Life Science Alliance
Nantes, France--(Newsfile Corp. - July 2, 2025) - InFlectis BioScience, a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases, is proud to announce the acceptance of its latest research article titled "Sephin1 reduces TDP-43 cytoplasmic mislocalization and improves motor neuron survival in ALS models" for publication in the peer-reviewed journal Life Science Alliance, effective July 1, 2025. To view the full announcement, including downloadable...
2025-07-02 8:27 AM EDT
FELIQS Announces $9 Million Series A Financing to Advance FLQ-101 Clinical Program for Retinopathy of Prematurity
Japan and New York, New York--(Newsfile Corp. - July 1, 2025) - FELIQS Corporation ("FELIQS"), a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, today announced the successful completion of a $9 million Series A funding round, co-led by a major American pharmaceutical company and Beyond Next Ventures Inc., with additional participation from, Japan Science and Technology Agency and existing investors,...
2025-07-01 8:21 AM EDT
Stonegate Updates Coverage on EnSilica PLC (ENSI) Mid-Year Update 1H 2025
Dallas, Texas--(Newsfile Corp. - June 26, 2025) - EnSilica PLC (AIM: ENSI): Stonegate Capital Partners updates their coverage on EnSilica PLC (AIM: ENSI) during the mid-year of 1H25. Through the beginning of calendar 2025, EnSilica PLC continued to build on its strategic initiatives and market strengths, achieving significant milestones. The Company's strong position and intellectual property in automotive, industrial, healthcare, and satellite connectivity applications for mixed-signal ASICs...
2025-06-26 9:22 AM EDT
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q4
Dallas, Texas--(Newsfile Corp. - June 26, 2025) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Subsequent to the 2025 year end, Burcon made continued significant progress in its strategic initiatives. The Company successfully scaled up commercial production of its pea protein isolate, marking a pivotal milestone in its go-to-market strategy. This scale up was accomplished at the Company's Galesburg...
2025-06-26 9:16 AM EDT
Chemify Launches the World's First Chemputation Facility Revolutionizing Molecular Design and Manufacture
Glasgow, Scotland--(Newsfile Corp. - June 20, 2025) - Chemify, the deep-tech pioneer fusing chemistry, robotics, computation and AI to digitise molecule creation, today unveiled its first Chemifarm--a fully automated chemistry facility regarded as the world's most advanced laboratory for molecular design and synthesis. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Chemify's first Chemifarm is a fully automated chemistry facility...
2025-06-20 3:20 AM EDT
Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING)
Dallas, Texas--(Newsfile Corp. - June 18, 2025) - Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners initiates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate reported 1Q25 results that highlight continued progress toward the commercial launch of its lead ADHD asset, CTx-1301. The Company remains focused on leveraging its proprietary Precision Timed Release (PTR) platform to address long-standing gaps in ADHD treatment. CTx- 1301 is uniquely designed to provide once-daily...
2025-06-18 8:00 AM EDT
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q1 2025
Dallas, Texas--(Newsfile Corp. - June 16, 2025) - Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq: AMTX). In the first quarter of 2025, Aemetis reported total revenues of $42.9M, compared to $72.6M in the same period last year, with the year-over-year decline primarily driven by shifts in timing in receiving new government biodiesel contracts in India. Net loss for the quarter was $24.5M, relatively flat versus a net loss of $24.2M in 1Q24, reflecting ongoing investment...
2025-06-16 4:31 PM EDT
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q1 FY26
Dallas, Texas--(Newsfile Corp. - June 13, 2025) - Hooker Furniture Corporation (NASDAQ: HOFT): Stonegate Capital Partners updates their coverage on Hooker Furniture Corporation (NASDAQ: HOFT). HOFT reported revenue, operating income, and adj EPS of $85.3M, ($3.6)M, and ($0.29), respectively. This compares to our/consensus estimates of $92.6M/$88.9M, ($2.5)M/($2.5)M, and ($0.16)/($0.15). It is noted that revenues were slightly below consensus estimates and posted a 8.8% y/y decrease. The...
2025-06-13 10:57 AM EDT
Lifordi Immunotherapeutics Presents Preclinical Data on Glucocorticoid Antibody Drug Conjugate LFD-200 to Treat Autoimmune and Inflammatory Diseases at EULAR 2025
Burlington, Massachusetts--(Newsfile Corp. - June 11, 2025) - Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented preclinical data on its lead program for LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells. Results of multiple in vitro and in vivo studies in mice and in non-human primates (NHPs) demonstrated that LFD-200 achieves targeted and sustained...
2025-06-11 8:41 AM EDT
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) Mid-Quarter Update FY25 Q4
Dallas, Texas--(Newsfile Corp. - June 10, 2025) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU) during the mid-quarter of 4Q25. Subsequent to the third quarter of 2025, Burcon made continued significant progress in its strategic initiatives. The Company successfully scaled up commercial production of its pea protein isolate, marking a pivotal milestone in its go-to-market strategy. This scale up was...
2025-06-10 9:48 AM EDT
Tevard Biosciences Names Dr. Elisabeth Gardiner Chief Scientific Officer to Lead Next Phase of tRNA-Based Therapies
Boston, Massachusetts--(Newsfile Corp. - June 10, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the appointment of Elisabeth Gardiner, Ph.D., as Chief Scientific Officer. With more than 25 years of leadership in drug discovery and development across the biotech and pharmaceutical sectors, Dr. Gardiner brings deep translational expertise that will accelerate Tevard's mission to...
2025-06-10 8:05 AM EDT
Phizzle to Launch Technical First for IoT Edge
San Francisco, California--(Newsfile Corp. - June 5, 2025) - Phizzle, Inc., will launch on June 10th a technical first for the IoT Edge: the industry's only purpose-built computer inside a gateway that is malware-hardened to format and normalize data from any device or machine in edge use cases, including pharma manufacturing, building automation and AI systems, among others. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Phizzle's...
2025-06-05 9:59 AM EDT
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
Dallas, Texas--(Newsfile Corp. - June 4, 2025) - Bio-Path Holdings, Inc. (OTCQB: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (OTCQB: BPTH) for Q1 2025. Bio-Path Holdings, Inc. (OTCQB: BPTH) is a clinical-stage biotechnology company based in Bellaire, Texas, pioneering RNA interference (RNAi) therapeutics through its proprietary DNAbilize® platform. This innovative technology employs neutral-charge, liposomal delivery of antisense oligonucleotides, enhancing...
2025-06-04 4:34 PM EDT
Q.ANT Debuts First Interactive Live Demonstration and New Benchmarks for Analog Photonic Computing at ISC 2025
Stuttgart, Germany--(Newsfile Corp. - June 4, 2025) - Q.ANT, today announced it will showcase live demonstrations of its photonic Native Processing Server (NPS) at ISC 2025, a leading global conference for high-performance computing (HPC). For the first time, attendees will be able to interact directly with functional photonic computing, witnessing how light can drive breakthroughs in energy and computational efficiency for AI, Physics Simulations, and other complex scientific workloads. To...
2025-06-04 4:30 AM EDT